From Our Affiliates

Tag: Alexion

A total of 7 posts are filed under Alexion
Forbes Reporters: How A $440,000 Drug Is Turning Alexion Into Biotech’s New Innovation Powerhouse
The pharmaceutical business is not kind to entrepreneurs. It takes more than a decade and hundreds of millions of dollars in venture capital… Continue Reading
Alexion and Cincinnati Children’s Launch Rare Disease Innovation Fund
Alexion Pharmaceuticals, Inc. and Cincinnati Children’s Hospital Medical Center today announced the establishment of a collaboration and… Continue Reading
Roche CEO Severin Schwan
Is Roche Going to Do Some Big Rare Disease Drug Deals?
So is Roche going to do some rare disease deals or not? Rumors of a possible buyout of Alexion and BioMarin– alternatively dissed and… Continue Reading
David Meeker, right, CEO of Genzyme Corp., speaks at a panel on the pricing of rare disease therapies.
MassBio Panel Tackles Why Rare Disease Treatments Cost So Much
One panel at the MassBio’s annual meeting on Thursday billed under the title, “Rare Disease Therapies: Is The Current Payer Model… Continue Reading
Chris Mann, Nestor Serrano, Jason George and Katrina Parker
Faircraft Records/Universal Republic Recording artist Chris Mann and Singer/Songwriter Katrina Parker to Perform at Global Genes | R.A.R.E Project’s Tribute to Champions of Hope™ Benefit
FOR IMMEDIATE RELEASE Actors Jason George, Nestor Serrano and Meagan Tandy will Serve as Celebrity Award Presenters; Henri Termeer, Former… Continue Reading
CHI Reports – How Biotech Companies are Shaping the Future in Rare Diseases
Biotech companies are navigating new trends in addressing rare diseases, conditions effecting 200,000 or fewer Americans. Jeremy Springhorn… Continue Reading
Rare Disease Drugs: A $1 Trillion Market?
Matthew Herper The Medicine Show; FORBES November 2010 Right now drugs for rare disorders are the sweet spot of the biotechnology industry.… Continue Reading